FDA Inspection 697187 — Hyland's Consumer Health Inc.
The FDA completed an inspection of Hyland's Consumer Health Inc. on October 28, 2010 in Los Angeles, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 28, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)